Volver al Panel








Johnson & Johnson (JNJ)
Valores intradiarios en tiempo real
Resumen del Mercado
From:
To:
JNJ Intraday
No data available
SímboloJNJ
Fecha de SalidaJan 2, 1962
CEOMr. Joaquin Duato
Empleados a Tiempo Completo138.2k
SectorHealthcare
IndustriaDrug Manufacturers - General
PaísUnited States
BolsaNYSE
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Rendimiento
| Período | Rentabilidad % | Cambio de Valor |
|---|---|---|
| 1 Día | -1.41% | -3.77 US$ |
| 5 Días | +3.24% | +8.28 US$ |
| 1 Mes | -1.98% | -5.33 US$ |
| 6 Meses | +15.97% | +36.34 US$ |
Analizando el Mercado con IA
Evaluando los últimos 30 días de historial y métricas fundamentales de JNJ...
Estadísticas Clave
Cap. de Mercado
635.07B
Relación P/E
40.03
Rend. de Div.
2.03%
Máx. 52 Semanas
$281.07
Mín. 52 Semanas
$184.66
Consenso de Analistas
CONSENSOCompra
ALCISTA1669.6%
NEUTRAL626.1%
BAJISTA14.3%
Objetivos de Precios de Analistas a 52 Semanas
Objetivo Mín.
$190.00
$190.00
Objetivo Máx.
$320.00
$320.00
Actual$263.84
Objetivo Prom.$279.41
Recomendaciones de Analistas
Precio Objetivo:$279.41($190.00 - $320.00)
Pensamientos de la Comunidad
Comparta su análisis y sentimiento sobre JNJ
Únase a la comunidad para compartir su análisis
Últimas Noticias para JNJ

Smith & Nephew (LSE:SN.) Stays Independent, Is It 8% Undervalued?
Simply Wall St.•25 oct 2026, 16:05



Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Motley Fool•24 oct 2026, 16:31


Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own
Simply Wall St.•24 oct 2026, 02:09
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires•23 oct 2026, 19:56
Sector Update: Healthcare Stocks Decline Friday Afternoon
MT Newswires•23 oct 2026, 17:51
Smith And Nephew Merger Talks With Johnson & Johnson Collapse Over Leadership Dispute
TIKR•23 oct 2026, 17:06